United States:
Partner David Gindler To Speak At Life Sciences Patent Network North America Fall Conference
28 October 2019
Milbank LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Milbank Intellectual Property and Litigation partner David
Gindler will present “Is Innovation Enough: New
Challenges to Patent Protection for Pharmaceuticals and
Biologics” at the 2019 Life Sciences Patent Network
North America Fall Conference on October 16 in San Francisco,
California.
Attendees, including in-house patent counsel, will come together
to hear updates on patent prosecution and enforceability from
global jurisdictions, meet in informal discussion groups, and
source specialist IP attorneys who can assist them with their IP
portfolio strategies over the coming year.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
USPTO Embraces AI Tools In New Guidance
Crowell & Moring LLP
On April 11, 2024, the USPTO published its "Guidance on Use of Artificial Intelligence-Based Tools in Practice Before the United States" in the Federal Register (the "Guidance"). As the title suggests...
Breaking Down The EPO's Revised Practice Guidelines
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The guidelines for examination in the European Patent Office instruct on the practice and procedure related to the examination of European patent applications...
USPTO Issues Guidance On Use Of AI-Based Tools
Greenberg Traurig, LLP
On April 11, 2024, the U.S. Patent and Trademark Office (USPTO) issued Guidance on Use of Artificial-Intelligence-Based Tools (Guidance), which applies existing rules and policies...